• Dovitinib (TKI-258) for RTK Cancer Assays

  2026-08-31

  Dovitinib (TKI-258) supports a practical workflow that connects multitargeted RTK inhibition with ERK, STAT3, STAT5, and apoptosis readouts. This guide shows how to design reproducible viability and signaling experiments, apply the compound in multiple myeloma and hepatocellular carcinoma research, and troubleshoot solubility, timing, and assay-interpretation problems.

• Phosphosignal Integrity in Translational Toxicology

  2026-08-31

  Mechanistic toxicology depends on preserving the phosphorylation states that define signaling networks. This thought-leadership article connects lanthanum-induced hepatic steatosis with rigorous sample handling and shows how a dual-component Phosphatase Inhibitor Cocktail can strengthen translational validation without overstating what ex vivo phosphoprotein measurements can prove.

• Trelagliptin and Insulin Resistance in Adipocytes

  2026-08-30

  The reference study shows that trelagliptin succinate improves insulin resistance in differentiated 3T3-L1 adipocytes by strengthening the PI-3K/AKT/GLUT4 signaling axis. Its integrated analysis of glucose uptake, membrane GLUT4, phosphorylation-related proteins, and adipokines provides a mechanistic framework for studying adipocyte insulin sensitivity, while remaining limited by its in vitro model.

• ER-Targeted EISA and Selective Cancer Cell Fate

  2026-08-29

  The reference study develops an alkaline phosphatase-responsive peptide that self-assembles at the endoplasmic reticulum of cancer cells. By combining enzyme-instructed self-assembly with p-toluenesulfonamide-mediated ER targeting, the authors enhanced ER stress and selectively induced apoptosis and necroptosis at lower effective concentrations.

• Lysis Buffer for Reliable Mouse Genotyping

  2026-08-28

  Improve mouse genotyping workflows with a lysis buffer designed for rapid tissue digestion and PCR-ready genomic DNA release. This practical guide covers workflow setup, assay decisions, optimization parameters, and troubleshooting for tail, toe, and ear samples.

• Viral RIPK3 Degradation Drives Inflammation

  2026-08-28

  Liu and colleagues identified a conserved orthopoxvirus factor, vIRD, that recruits SCF ubiquitin-ligase machinery to drive proteasomal degradation of RIPK3. The study shows that this apparently anti-necroptotic mechanism can increase viral replication and inflammatory disease in vivo, providing a mechanistic link between pathogen evolution, host-cell death, and poxvirus virulence.

• AmpliFold Capture-and-Release for LFA Sensitivity

  2026-08-27

  The ChemRxiv preprint introduces AmpliFold, a capture-and-release architecture that uses triggered release and high-affinity rebinding to reduce the kinetic burden on lateral flow assay test lines. In a HER2 model, linker and receptor-density optimization produced up to 16-fold lower detection limits and a 12-fold sensitivity improvement with large gold nanoparticles, while also highlighting important translation constraints.

• Pronase E for Ferroptosis Protein Preparation

  2026-08-27

  Pronase E provides broad, high-activity proteolysis for reproducible protein digestion, peptide mapping, and proteomics-oriented sample preparation. This guide translates the CUL3–MTDH ferroptosis findings in triple-negative breast cancer into practical assay workflows while clearly separating evidence from optimization recommendations.

• Protease Inhibitor Cocktail for MS Proteomics

  2026-08-26

  Discover how a Protease Inhibitor Cocktail can improve protein degradation prevention in MS-oriented extraction workflows. This guide connects inhibitor selection with CYR61–migrasome research and practical assay-control decisions.

• Targeting Mitocytosis to Enhance Mitochondrial Therapy

  2026-08-26

  Deng and colleagues show that mitocytosis can weaken mitochondria-targeted antimetastatic therapy in migrasome-rich breast tumors. Their hybrid membrane nanoplatform combines mitochondrial damage with integrin-mediated mitocytosis inhibition, substantially improving treatment activity in the 4T1 model.

• Cell lysis buffer for WB and IP: CAF Assays

  2026-08-25

  Build cleaner Western blot, co-IP, and signaling workflows around a non-denaturing extraction system designed to preserve both proteins and labile interactions. This guide translates the CAF–ANGPTL4–IQGAP1 prostate cancer study into practical sample-handling, assay-selection, and troubleshooting decisions.

• PPACK Dihydrochloride in Thrombin Assays

  2026-08-25

  PPACK Dihydrochloride provides an irreversible thrombin clamp for separating coagulation-driven effects from receptor-specific platelet signaling. This guide translates its high-affinity chemistry into practical assay workflows, controls, and troubleshooting strategies for reproducible blood coagulation research.

• PMSF for Reliable Protein Extraction

  2026-08-24

  Learn how to use PMSF as a focused serine protease safeguard for tissue, cell, and Western blot lysates. The workflow also shows how better sample preservation can strengthen ferroptosis and cardiomyopathy studies without confusing a sample-preparation reagent with a live-cell mechanism.

• Pronase E for Ferroptosis Proteomics

  2026-08-24

  Discover how Pronase E (Activity ≥ 7000 U/g) can strengthen exploratory protein digestion, limited-proteolysis, and peptide-mapping workflows related to ferroptosis research. This practical guide distinguishes sample-preparation utility from mechanistic proof in CUL3–MTDH studies.

• Phosphatase Inhibitor Cocktail for Signaling Assays

  2026-08-23

  Protect transient serine/threonine and tyrosine phosphorylation during lysis, immunoblotting, kinase assays, and mass spectrometry. The dual-tube format separates solvent systems and inhibitor coverage, making sequential addition a practical advantage for signaling workflows that demand reproducibility.

703 records 1/47 page Next 12345 下5页 Last page